Jennifer A Fox Net Worth - Insider Trades and Bio as of Jun 11, 2026

PROKPROKIDNEY CORP.SEC CIK: 0001841557

Estimated Net Worth

Last Updated: May 27, 2026 12:02 AM EST

Transaction Summary

Total Transactions19

Buy-Sell Ratio—

Buy Transactions0

Sell Transactions0

Transaction Volume

Total Volume$0.00

Net Volume$0.00

Buy Volume$0.00

Sell Volume$0.00

Trade Analysis

AVG Trade Size$0.00

Largest Trade$0.00

Most Active MonthFeb

Most Active Year2024

Trading Sentiment

OverallNeutral

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Jennifer A. Fox does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., PROKIDNEY CORP., Apogee Therapeutics, Inc., and Zenas BioPharma, Inc..

2024 was Jennifer A. Fox's most active year for acquiring shares with 5 total transactions. Jennifer A. Fox's most active month to acquire stocks was the month of January. 2022 saw Jennifer A. Fox paying a total of $0.00 for 1,209,370 shares, this is the most they've acquired in one year.

Holdings & Transactions

PROKprokidney corp.

Updated: Jun 02, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	125.86K	—	—	Jun 02, 2025	125.86K	Grant	—	May 29	View
From 4	—	9.54K	—	—	Sep 04, 2024	9.54K	Grant	—	Sep 03	View
From 4	—	62.56K	—	—	Jun 03, 2024	62.56K	Grant	—	May 30	View
From 4	—	89.15K	—	—	Jul 13, 2023	89.15K	Grant	—	Jul 12	View
From 4	—	129.37K	—	—	Sep 22, 2022	129.37K	Grant	—	Sep 20	View
From 3	—	—	—	—	Jul 13, 2022	—	—	—	—	View

APGEapogee therapeutics, inc.

Updated: Jun 20, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	14.46K	—	—	Jun 20, 2025	14.46K	Grant	—	Jun 17	View
From 4	—	10.37K	—	—	Jun 07, 2024	10.37K	Grant	—	Jun 05	View
From 3/A	—	—	—	—	Jul 17, 2023	34.82K	—	—	—	View
From 3	—	—	—	—	Jul 13, 2023	30.19K	—	—	—	View

ZBIOzenas biopharma, inc.

See Remarks Officer

Updated: Jun 12, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	150.00K	—	—	Jun 12, 2025	150.00K	Grant	—	Jun 10	View
From 4	—	8.13K	—	—	Dec 18, 2024	8.13K	Grant	—	Dec 16	View
From 4	—	155.00K	—	—	Sep 16, 2024	155.00K	Grant	—	Sep 12	View
From 3	—	—	—	—	Sep 12, 2024	—	—	—	—	View

NUVBnuvation bio inc.

Chief Financial Officer Officer

Updated: Mar 02, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	600.00K	—	—	Mar 02, 2023	604.48K	Grant	—	Feb 28	View
From 4	—	480.00K	—	—	Aug 31, 2022	480.00K	Grant	—	Aug 29	View
From 4	—	600.00K	—	—	Mar 02, 2022	601.71K	Grant	—	Feb 28	View
From 4	—	957.44K	—	—	Feb 12, 2021	957.44K	Grant	—	Feb 10	View
From 3	—	—	—	—	Feb 12, 2021	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions